Physiologic aspects in human lung transplantation.

Shinichiro Miyoshi, Yoshihiko Mochizuki, Sensuke Nagai, Satoru Kobayashi, Norio Seki

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Heart-lung transplantation (HLT), followed by single lung transplantation (SLT) and subsequently bilateral lung transplantation (BLT) have been developed as treatments for patients with end-stage pulmonary diseases. Initially, SLT was limited to idiopathic pulmonary fibrosis (IPF) cases and thought to be contraindicated not only for infectious diseases, but also for non-infectious diseases, including pulmonary emphysema (PE) and primary pulmonary hypertension (PPH), based on physiologic points of view. However, SLT is now widely performed for those non-infectious diseases and most of the recipients return to a normal active life. It is quite possible that BLT is superior to SLT in terms of pulmonary function, and it has been reported that BLT is better for PE and PPH patients in regards to perioperative course, postoperative exercise capacity, and long-term survival. For those situations and because of the present scarcity of donor organs, SLT must be utilized for selected non-infectious diseases for which it is safe and effective. When a single lung is replaced for IPF, PE, and PPH recipients, different physiologic situations are produced postoperatively, the understanding of which is extremely important to achieve good results, not only in the perioperative but also in the long term.

Original languageEnglish
Pages (from-to)73-79
Number of pages7
JournalAnnals of Thoracic and Cardiovascular Surgery
Volume11
Issue number2
Publication statusPublished - 2005
Externally publishedYes

Fingerprint

Lung Transplantation
Pulmonary Emphysema
Idiopathic Pulmonary Fibrosis
Heart-Lung Transplantation
Lung
Lung Diseases
Communicable Diseases
Tissue Donors
Exercise
Survival

Cite this

Miyoshi, S., Mochizuki, Y., Nagai, S., Kobayashi, S., & Seki, N. (2005). Physiologic aspects in human lung transplantation. Annals of Thoracic and Cardiovascular Surgery, 11(2), 73-79.

Physiologic aspects in human lung transplantation. / Miyoshi, Shinichiro; Mochizuki, Yoshihiko; Nagai, Sensuke; Kobayashi, Satoru; Seki, Norio.

In: Annals of Thoracic and Cardiovascular Surgery, Vol. 11, No. 2, 2005, p. 73-79.

Research output: Contribution to journalArticle

Miyoshi, S, Mochizuki, Y, Nagai, S, Kobayashi, S & Seki, N 2005, 'Physiologic aspects in human lung transplantation.', Annals of Thoracic and Cardiovascular Surgery, vol. 11, no. 2, pp. 73-79.
Miyoshi S, Mochizuki Y, Nagai S, Kobayashi S, Seki N. Physiologic aspects in human lung transplantation. Annals of Thoracic and Cardiovascular Surgery. 2005;11(2):73-79.
Miyoshi, Shinichiro ; Mochizuki, Yoshihiko ; Nagai, Sensuke ; Kobayashi, Satoru ; Seki, Norio. / Physiologic aspects in human lung transplantation. In: Annals of Thoracic and Cardiovascular Surgery. 2005 ; Vol. 11, No. 2. pp. 73-79.
@article{6c9cb9c3a54c4a128ff3a3132d84b83a,
title = "Physiologic aspects in human lung transplantation.",
abstract = "Heart-lung transplantation (HLT), followed by single lung transplantation (SLT) and subsequently bilateral lung transplantation (BLT) have been developed as treatments for patients with end-stage pulmonary diseases. Initially, SLT was limited to idiopathic pulmonary fibrosis (IPF) cases and thought to be contraindicated not only for infectious diseases, but also for non-infectious diseases, including pulmonary emphysema (PE) and primary pulmonary hypertension (PPH), based on physiologic points of view. However, SLT is now widely performed for those non-infectious diseases and most of the recipients return to a normal active life. It is quite possible that BLT is superior to SLT in terms of pulmonary function, and it has been reported that BLT is better for PE and PPH patients in regards to perioperative course, postoperative exercise capacity, and long-term survival. For those situations and because of the present scarcity of donor organs, SLT must be utilized for selected non-infectious diseases for which it is safe and effective. When a single lung is replaced for IPF, PE, and PPH recipients, different physiologic situations are produced postoperatively, the understanding of which is extremely important to achieve good results, not only in the perioperative but also in the long term.",
author = "Shinichiro Miyoshi and Yoshihiko Mochizuki and Sensuke Nagai and Satoru Kobayashi and Norio Seki",
year = "2005",
language = "English",
volume = "11",
pages = "73--79",
journal = "Annals of Thoracic and Cardiovascular Surgery",
issn = "1341-1098",
publisher = "Japanese Association for Coronary Artery Surgery",
number = "2",

}

TY - JOUR

T1 - Physiologic aspects in human lung transplantation.

AU - Miyoshi, Shinichiro

AU - Mochizuki, Yoshihiko

AU - Nagai, Sensuke

AU - Kobayashi, Satoru

AU - Seki, Norio

PY - 2005

Y1 - 2005

N2 - Heart-lung transplantation (HLT), followed by single lung transplantation (SLT) and subsequently bilateral lung transplantation (BLT) have been developed as treatments for patients with end-stage pulmonary diseases. Initially, SLT was limited to idiopathic pulmonary fibrosis (IPF) cases and thought to be contraindicated not only for infectious diseases, but also for non-infectious diseases, including pulmonary emphysema (PE) and primary pulmonary hypertension (PPH), based on physiologic points of view. However, SLT is now widely performed for those non-infectious diseases and most of the recipients return to a normal active life. It is quite possible that BLT is superior to SLT in terms of pulmonary function, and it has been reported that BLT is better for PE and PPH patients in regards to perioperative course, postoperative exercise capacity, and long-term survival. For those situations and because of the present scarcity of donor organs, SLT must be utilized for selected non-infectious diseases for which it is safe and effective. When a single lung is replaced for IPF, PE, and PPH recipients, different physiologic situations are produced postoperatively, the understanding of which is extremely important to achieve good results, not only in the perioperative but also in the long term.

AB - Heart-lung transplantation (HLT), followed by single lung transplantation (SLT) and subsequently bilateral lung transplantation (BLT) have been developed as treatments for patients with end-stage pulmonary diseases. Initially, SLT was limited to idiopathic pulmonary fibrosis (IPF) cases and thought to be contraindicated not only for infectious diseases, but also for non-infectious diseases, including pulmonary emphysema (PE) and primary pulmonary hypertension (PPH), based on physiologic points of view. However, SLT is now widely performed for those non-infectious diseases and most of the recipients return to a normal active life. It is quite possible that BLT is superior to SLT in terms of pulmonary function, and it has been reported that BLT is better for PE and PPH patients in regards to perioperative course, postoperative exercise capacity, and long-term survival. For those situations and because of the present scarcity of donor organs, SLT must be utilized for selected non-infectious diseases for which it is safe and effective. When a single lung is replaced for IPF, PE, and PPH recipients, different physiologic situations are produced postoperatively, the understanding of which is extremely important to achieve good results, not only in the perioperative but also in the long term.

UR - http://www.scopus.com/inward/record.url?scp=22844438123&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22844438123&partnerID=8YFLogxK

M3 - Article

C2 - 15900236

AN - SCOPUS:22844438123

VL - 11

SP - 73

EP - 79

JO - Annals of Thoracic and Cardiovascular Surgery

JF - Annals of Thoracic and Cardiovascular Surgery

SN - 1341-1098

IS - 2

ER -